February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
Dec. 19, 2025 — Washington University in St. Louis (WashU) has been recognized as a Focused Ultrasound Center of ...
December 23, 2025 
Dec. 12, 2025 — Hyperfine, Inc. has announced that it has received FDA clearance for a new multi-direction diffusion ...
December 15, 2025 
Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...
December 10, 2025 
Healthcare has reached a critical juncture. The World Economic Forum estimates that global medical costs will see double ...
December 04, 2025 
Nov. 20, 2025 — Avatar Medical and Barco have launched Eonis Vision, marking a new evolution in how medical imaging is ...
November 20, 2025 
Nov. 19, 2025 — Royal Philips has announced an extended partnership with Cortechs.ai. Together, the companies will ...
November 19, 2025 
Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...
November 06, 2025 
Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North ...
November 03, 2025 
Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...
October 27, 2025 
Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced ...
October 20, 2025 